2,454 followers
Could Camrelizumab Plus Chemotherapy Improve Clinical Outcomes in Advanced Malignancy? A Systematic Review and Network Meta-Analysis #lymphoma #lymsm https://t.co/tX2rRsfQlF
Could Camrelizumab Plus Chemotherapy Improve Clinical Outcomes in Advanced Malignancy? A Systematic Review and Network Meta-Analysis #lymphoma #lymsm https://t.co/tX2rRsfQlF
New research: Could Camrelizumab Plus Chemotherapy Improve Clinical Outcomes in Advanced Malignancy? A Systematic Review and Network Meta-Analysis: Purpose Camrelizumab is a novel programmed cell death 1 (PD-1) inhibitor. To determine the… https://t.co/Bap